Marc Rubin - 24 Jan 2022 Form 4 Insider Report for GALECTIN THERAPEUTICS INC (GALT)

Role
Director
Signature
Jack W. Callicutt, by power of attorney
Issuer symbol
GALT
Transactions as of
24 Jan 2022
Transactions value $
$0
Form type
4
Filing time
25 Jan 2022, 15:35:42 UTC
Previous filing
05 Jan 2022
Next filing
31 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction GALT Stock Option (right to buy) Award $0 +40,000 $0 40,000 24 Jan 2022 Common Stock 40,000 $1.98 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options were issued pursuant to the Galectin Therapeutics Inc. 2019 Omnibus Equity Incentive Plan.
F2 The options vest 100% on December 31, 2022.